Display options
Share it on

Endocr Pathol. 1999 Jun;10(2):103-8. doi: 10.1007/BF02739822.

Expression of leukemia inhibitory factor in craniopharyngioma.

Endocrine pathology

A Tran, K Kovacs, L Stefaneanu, G Kontogeorgos, B W Scheithauer, S Melmed

Affiliations

  1. Department of Medicine, St., Michaels Hospital, University of Toronto, Toronto, Ontario, Canada.
  2. Department of Pathology, St. Michael's Hospital, 30 Bond Street, MSA 1W8, Toronto, Ontario, Canada.
  3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN (BWS).
  4. Division of Endocrinology and Metabolism Cedars-Sinai Research Institute, UCLA School of Medicine, Los Angeles, CA.

PMID: 27519214 DOI: 10.1007/BF02739822

Abstract

It has recently been reported that overexpression of leukemia inhibitory factor (LIF) in mice transgenic for LIF causes invagination of the anterior wall of Rathke's pouch leading to the formation of cysts lined by LIF immunoreactive epithelial cells. Strong immunoreactivity was also found in human Rathke's cleft cysts. Because such cysts and craniopharyngiomas share a common histogenesis, we raised the question of whether LIF is also expressed in craniopharyngioma.Fourteen histologically verified craniopharyngiomas of adamantinomatous type were examined for LIF immunoreactivity using the streptavidin-biotin-peroxidase complex method. Rabbit-anti-LIF antibody dilution 1:40) was applied to tissues having undergone antigen retrieval (microwaving in citrate buffer at pH 6). For positive control, nontumorous pituitary tissues were used. Primary antibody substituted with phosphate-buffered saline served as a negative control.By immunocytochemistry, the epithelial cells of all 14 craniopharyngiomas were LIF immunoreactive, showing varying degrees of staining intensity. In comparison, the connective tissue components of the tumors were immunonegative.Our study provides evidence that LIF is expressed in the epithelial cells of craniopharyngioma. Further investigation is required to elucidate the possible role of LIF in the development and progression of craniopharyngiomas.

Keywords: Craniopharyngioma; Rathke’s cleft cyst; immunocytochemistry; leukemia inhibitory factor; pituitary

References

  1. J Clin Invest. 1995 Mar;95(3):1288-98 - PubMed
  2. Endocrinology. 1998 May;139(5):2209-16 - PubMed
  3. Endocrinology. 1998 May;139(5):2201-8 - PubMed
  4. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):698-702 - PubMed
  5. Int J Cancer. 1979 Nov 15;24(5):616-23 - PubMed
  6. Int Rev Immunol. 1998;16(3-4):397-426 - PubMed
  7. Crit Rev Oncol Hematol. 1998 Aug;28(2):73-90 - PubMed
  8. Jpn J Cancer Res. 1995 Jun;86(6):562-7 - PubMed
  9. Int J Cancer. 1996 May 16;66(4):515-9 - PubMed
  10. Int J Cell Cloning. 1991 Mar;9(2):95-108 - PubMed
  11. Anat Embryol (Berl). 1988;178(4):327-36 - PubMed
  12. Arch Pathol Lab Med. 1996 Jun;120(6):560-8 - PubMed
  13. J Immunol. 1990 Apr 1;144(7):2592-8 - PubMed
  14. EMBO J. 1987 Dec 20;6(13):3995-4002 - PubMed
  15. J Cell Physiol. 1969 Dec;74(3):223-34 - PubMed
  16. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7833-5 - PubMed
  17. Breast Cancer Res Treat. 1998 Mar;48(2):165-74 - PubMed
  18. Cancer. 1995 Jun 15;75(12):2971-7 - PubMed
  19. J Neurosurg. 1994 Jun;80(6):1018-25 - PubMed
  20. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11408-12 - PubMed
  21. J Clin Invest. 1997 May 15;99(10):2462-9 - PubMed
  22. J Reprod Immunol. 1997 Jul;33(3):189-201 - PubMed
  23. J Neurosurg. 1995 Aug;83(2):206-14 - PubMed
  24. Pathol Annu. 1985;20 Pt 1:67-155 - PubMed

Publication Types